Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.
Publisher
Subject Area
Open Acess
Quartille
Countries
H-Index
1125 AN UNDER-RECOGNIZED CAUSE OF VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH: A CASE REPORT
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when?
548 ROLE OF NEW ANTIDIABETIC DRUGS IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy
Severe calcified paravalvular leak: usefulness of intravascular lithotripsy technology
Antiplatelet Therapy for Peripheral Artery Disease
Glycemic variability in the development of cardiovascular complications in diabetes
Antiplatelet therapy for peripheral artery disease
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study
Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention
High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions
Prognostic Role of Platelet Reactivity in Patients With Acute Coronary Syndromes
Stent thrombosis and platelet reactivity
TCT-297 A new prognostic risk score including platelet reactivity for bleeding after percutaneous coronary intervention via the femoral approach
A model of good clinical practice in applied research in complementary alternative medicine: update on Guna's clinical research project
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)
A HEIGHTENED PLATELET RESPONSE TO CLOPIDOGREL BY POINT-OF-CARE TESTING PREDICTS BLEEDING OUTCOMES IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. RESULTS OF ARMYDA-BLEEDS (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY-BLEEDING STUDY)
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial
